<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Etoposide upregulates survival favoring sphingosine-1-phosphate in etoposideresistant retinoblastoma cells</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Vinodh</forename><surname>Kakkassery</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">Ruhr-University</orgName>
								<address>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Skosyrski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Lüth</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nutrition Science</orgName>
								<orgName type="institution">University Potsdam</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Kleuser</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nutrition Science</orgName>
								<orgName type="institution">University Potsdam</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Van Der Giet</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Tate</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Strathclyde Institute of Pharmacy and Biomedical Sciences</orgName>
								<orgName type="institution">University of Strathclyde</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Reinhard</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Cell Morphology and Molecular Neurobiology</orgName>
								<orgName type="department" key="dep2">Faculty of Biology and Biotechnology</orgName>
								<orgName type="institution">Ruhr-University</orgName>
								<address>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Faissner</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Cell Morphology and Molecular Neurobiology</orgName>
								<orgName type="department" key="dep2">Faculty of Biology and Biotechnology</orgName>
								<orgName type="institution">Ruhr-University</orgName>
								<address>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">N</forename><surname>Kociok</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Ophthalmology</orgName>
								<orgName type="institution">Ruhr-University</orgName>
								<address>
									<settlement>Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Universitätsklinikum Knappschaftskrankenhaus Bochum -Ruhr University Bochum In</orgName>
								<address>
									<postCode>23-25 2 44892</postCode>
									<settlement>Schornau, Bochum</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Etoposide upregulates survival favoring sphingosine-1-phosphate in etoposideresistant retinoblastoma cells</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">510E7F31C8B50879FD75C7753F3FAB23</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>Retinoblastomasphingosine-1-phosphatechemotherapy resistance</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Introduction: Improved knowledge of retinoblastoma chemotherapy resistance is needed to raise treatment efficiency.</s><s>The objective of this study was to test whether etoposide alters glucosyl-ceramide, ceramide, sphingosine and sphingosine-1phosphate (sphingosine-1-P) levels in parental retinoblastoma cells (WERI Rb1) or their etoposide-resistant subclones (WERI EtoR).</s></p><p><s>Material and methods: WERI Rb1 and WERI EtoR were incubated with 400 ng/ml etoposide for 24 hours.</s><s>Levels of glucosyl-ceramides, ceramides, sphingosine, sphingosine-1-P were detected by Q-TOF mass spectrometry.</s><s>Statistical analysis was done by ANOVA followed by Tukey post-hoc test (p&lt;0.05)</s></p><p><s>The mRNA expressions of sphingolipid pathway enzymes in WERI Rb1, WERI EtoR and four human retinoblastoma tissue samples were analyzed by quantitative real time PCR.</s></p><p><s>Results: Pathways enzymes mRNA expression confirmed similarities of human sphingolipid metabolism in both cell lines and tissue samples, but different relative expression.</s><s>Significant up-regulation of sphingosine was seen in both cell lines (p&lt;0.001).</s><s>Only sphingosine-1-P up-regulation was significantly increased in WERI EtoR (p&lt;0.01), but not in WERI Rb1 (p&gt;0.2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion:</head><p><s>Both cell lines upregulate pro-apoptotic sphingosine after etoposide incubation, but only WERI EtoR produces additional survival favorable sphingosine-1-P.</s><s>These data may suggest a role of sphingosine-1-P in retinoblastoma chemotherapy resistance, although this seems not to be the only resistance mechanism.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Retinoblastoma is the most common malignant eye tumor of the childhood with a lethality rates that reaches up to 95% if left untreated (1, 2).</s><s>Currently, the most effective treatment in retinoblastoma is the surgical removal/enucleation of the affected eye, with obvious disadvantages for the child <ref type="bibr" target="#b1">(2)</ref>.</s><s>In bilateral involvement, chemotherapy is administered in order to facilitate partial tumor regression and size reduction, but chemotherapy resistance frequently leads all too often to limited efficiency <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b4">(4)</ref><ref type="bibr" target="#b6">(5)</ref><ref type="bibr" target="#b8">(6)</ref><ref type="bibr" target="#b9">(7)</ref><ref type="bibr" target="#b10">(8)</ref><ref type="bibr" target="#b11">(9)</ref><ref type="bibr" target="#b12">(10)</ref>.</s></p><p><s>Therefore, new adjuvant therapy is needed to raise therapy efficiency in chemotherapy resistant retinoblastoma.</s></p><p><s>Recent advances in research have elucidated a central role of sphingolipids in cellular apoptosis and survival signaling mechanisms <ref type="bibr" target="#b14">(11)</ref>.</s><s>Of particular interest is the apoptotic effect of up-regulation of glucosyl-ceramide, ceramide, and sphingosine expression, whereas sphingosine-1-phosphate (sphingosine-1-P) upregulation induces cell survival <ref type="bibr" target="#b14">(11)</ref> (see fig <ref type="figure" target="#fig_2">1</ref>).</s><s>The apoptotic effect of sphingolipids has been demonstrated in various tumors including stomach, lung and kidney cancer, non-Hodgkin-lymphoma, colon adenomacarcinoma, astrocytoma, glioblastoma, and breast cancer <ref type="bibr" target="#b15">(12)</ref><ref type="bibr" target="#b17">(13)</ref><ref type="bibr" target="#b19">(14)</ref><ref type="bibr" target="#b21">(15)</ref><ref type="bibr" target="#b22">(16)</ref><ref type="bibr" target="#b24">(17)</ref><ref type="bibr" target="#b26">(18)</ref><ref type="bibr" target="#b28">(19)</ref><ref type="bibr" target="#b30">(20)</ref><ref type="bibr" target="#b31">(21)</ref>.</s></p><p><s>Furthermore, glucosyl-ceramide, ceramide and sphingosine up-regulation has been associated with increased chemotherapy efficiency in in vitro and in vivo tumor models <ref type="bibr" target="#b33">(22)</ref><ref type="bibr" target="#b35">(23)</ref><ref type="bibr" target="#b37">(24)</ref>.</s><s>In contrast, sphingosine-1-P down-regulation has been accompanied with increased chemotherapy efficiency in tumor cells <ref type="bibr" target="#b38">(25)</ref><ref type="bibr" target="#b39">(26)</ref><ref type="bibr" target="#b41">(27)</ref><ref type="bibr" target="#b42">(28)</ref>.</s></p><p><s>Therefore, we hypothesized, that chemotherapy treatment in resistant retinoblastoma cells induces sphingosine-1-P expression, thus reducing chemotherapy efficiency.</s><s>The objective of this study was to test, whether etoposide alters the level of glucosyl-ceramide, ceramide, sphingosine, and sphingosine-1-P in parental retinoblastoma cells (WERI Rb1) or their etoposide-resistant subclone (WERI EtoR).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>6</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authentication verifications of WERI Rb cell lines</head><p><s>DNA fingerprinting of both human WERI Rb cell lines was confirmed by carried out DNA profiling using 8 different and highly polymorphic short tandem repeat (STR) loci.</s></p><p><s>Authentication verifications were done by Leibniz Institute DSMZ -German Collection of Microorganisms and Cell Cultures (www.dsmz.de).</s><s>Generated STR profiles of used cell lines showed a full match of the respective parental reference STR profiles as indicated by a search of the database of cell banks ATCC (USA), JCRB (Japan), RIKEN (Japan), KCLB (Korea) and DSMZ.</s><s>Samples of WERI Rb1 and WERI EtoR were taken from authenticated cell cultures.</s><s>Also, both WERI Rb cell lines were tested for presence of mitochondrial DNA sequences from rodent cells as mouse, rat, Chinese and Syrian hamster.</s><s>Results revealed no detection of any mitochondrial sequences from mouse, rat or Chinese and Syrian hamster cells in the human samples at a detection limit of 1:10 5 .</s><s>The samples are derived of pure human cell cultures.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>WERI Rb1 and WERI Rb1 etoposide-resistant subclones (WERI EtoR)</head><p><s>The retinoblastoma cell line WERI Rb1 and the etoposide-resistant WERI Rb1 (WERI EtoR) subclone were a courtesy of Dr. H. Stephan (University Hospital, Essen, Germany) <ref type="bibr" target="#b43">(29)</ref>.</s><s>Both cell lines were cultivated in cell culture medium containing DMEM supplemented with 15% FBS, 4 mM L-glutamine, 50 mM ß-mercaptoethanol, 10 mg insulin/mL, and penicillin/streptomycin at 37 °C at 10% CO 2 and 80% humidity <ref type="bibr" target="#b44">(30)</ref>.</s><s>DAPI/propidium iodide assays to determine apoptosis/necrosis rate confirmed chemotherapy sensitivity of WERI Rb1, but resistance of WERI EtoR after 400 ng/ml</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative PCR (RT-PCR) for sphingolipid enzyme miRNA in retinoblastoma samples and cell lines</head><p><s>To confirm the expression of sphingolipid enzyme mRNA, we used tumor tissue from four anonymous diagnosed retinoblastoma patients after enucleation.</s><s>Biodata have been summarized in tab 1. Ethic committee approval of Charité Universitätsmedizin (Berlin, Germany) was obtained and the study was conducted following the guidelines of the Helsinki declaration.</s><s>To obtain mRNA, 5 x 10 6 -1 x 10 7 sensitive WERI Rb1 (n=5) and resistant WERI EtoR cells (n=5) were snap frozen in liquid nitrogen and stored at -80°C until RNA isolation.</s><s>Total RNA was extracted from four different retinoblastoma tumor tissues.</s><s>The Gene Elute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, Munich, Germany) was used for total RNA extraction following manufacturer's instructions.</s><s>Purity and concentration of RNA was quantified in a BioSpectrometer (Eppendorf, Hamburg, Germany).</s><s>For cDNA synthesis, 1 µg total RNA was reverse-transcribed to cDNA using the First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Darmstadt, Germany).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative Real-time PCR</head><p><s>The gene expression levels in the samples were determined by reverse-transcription quantitative real-time PCR (RT-qPCR) using PowerUp TM SYBR Green chemistry (Thermo Fisher Scientific, UK).</s><s>PCR primers for the genes of interest were designed using Primer-BLAST <ref type="bibr" target="#b48">(34)</ref>.</s><s>Where possible, the primers spanned exons and all of PCR products were within the 136-150 bp size range.</s><s>Primer sequences are listed in tab 2.</s></p><p><s>Beta-2-microglobulin (B2M; NM_004048.2) was chosen as the reference gene for normalization purposes.</s><s>2.5 ng of cDNA was used per 10 μl RT-qPCR with 500 nM of the sense and antisense primers and run on a StepOnePlus real-time PCR system (Applied Biosystems, UK).</s><s>PCRs were carried out in triplicate per primer set per sample.</s></p><p><s>The resultant cycle threshold values (C T ) were used to obtain the delta C T (ΔC T =C T target gene -C T B2M reference gene) for each sample.</s><s>The normalized expression levels of the genes of interest were calculated as 2 ^(-ΔCT) .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Data are presented as mean ± SD and mean ± SEM unless otherwise stated.</s><s>Statistical Analysis was done by ANOVA followed by a Tukey post-hoc test using Statistical Software (V10.0,</s><s>Statsoft, Tulsa, Ok, USA).</s><s>P-values below 0.05 were considered statistically significant.</s></p><p><s>10</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Retinoblastoma tissue biodata</head><p><s>Four human retinoblastoma patients' samples were included in this study.</s><s>One patient had no treatment before enucleation, one had chemotherapy before, one had beam radiation before and one had combined chemotherapy/beam radiation before.</s><s>Three Taken together, the similar sphingolipid enzyme mRNAs, and especially SPHK1 and SPHK2, are at all expressed in four human retinoblastoma samples and in WERI Rb1 and WERI EtoR.</s><s>Differences have been found between native tissue and both cell lines in relative expression of these enzymes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The objective of this study was to test, whether etoposide alters the level of glucosylceramide, ceramide, sphingosine, and sphingosine-1-P in parental retinoblastoma cells (WERI Rb1) or their etoposide-resistant subclone (WERI EtoR).</s><s>Data from this study demonstrate significant upregulation of sphingosine expression following etoposide treatment in WERI Rb1 and WERI EtoR and therefore presume an apoptotic signal in both cell lines.</s><s>Up-regulation of survival favoring sphingosine-1-P was only seen in therapy-resistant WERI EtoR following etoposide treatment, but not in chemotherapysensitive WERI Rb1.</s><s>Therefore, we assume a survival signal in WERI EtoR, which might explain etoposide-resistance.</s><s>In accordance with the sphingosine data, small decrease in glucosyl-ceramide and ceramide levels was detected following etoposide therapy, which might be a result of a consumptive shift to sphingosine in WERI Rb1 and WERI EtoR.</s><s>As etoposide-induced downregulation of apoptotic ceramide and at the same time cell death in WERI Rb1, this suggests that there might be other apoptotic mechanisms leading to etoposide-vulnerable WERI Rb1, which is not in WERI EtoR.</s><s>Taken together, these data may indicate a functional role of sphingosine-1-P in retinoblastoma chemotherapy resistance, but seems not to be the only resistance mechanism.</s></p><p><s>Experiments to demonstrate sphingolipid differences following treatment were conducted with previously described etoposide-sensitive WERI Rb1 and etoposideresistant WERI EtoR <ref type="bibr" target="#b43">(29)</ref>.</s><s>Key analysis of our study, measurements of sphingosine, sphingosine-1-P, glucosyl-ceramide and ceramide, were performed by Q-TOF mass spectrometry, as described before (31-33).</s><s>Realizing the role of sphingolipid enzymes, and especially SPHK1 and SPHK2, in sphingosine-1-P chemotherapy resistance of different tumor cells, we investigated their mRNA expression in four human retinoblastoma samples and in WERI Rb1 and WERI EtoR in this study.</s><s>Therefore, we have not only seen upregulation of sphingosine-1-P in retinoblastoma chemotherapyresistant cells, but also demonstrated similarity of sphingolipid metabolism in the used WERI Rb1 and WERI EtoR cell models as well in human retinoblastoma tissue.</s></p><p><s>Our results are consistent with findings from other study groups for sphingosine-1-P and SPHK1 and 2 in other diverse tumors.</s><s>For example, SPHK1-siRNA-knockout experiments showed a reduction of sphingosine-1-P-levels and a reduced proliferation in prostatic tumor cells, pancreatic tumor cells and leukemia cells <ref type="bibr" target="#b38">(25)</ref><ref type="bibr" target="#b39">(26)</ref><ref type="bibr" target="#b41">(27)</ref><ref type="bibr" target="#b42">(28)</ref><ref type="bibr" target="#b49">35)</ref>.</s><s>Furthermore, sphingosine-1-P expression upregulation was seen after treatment in daunorubicinresistant leukemia <ref type="bibr" target="#b42">(28,</ref><ref type="bibr" target="#b49">35)</ref>.</s><s>Interestingly, increased SPHK1 expression have been also demonstrated in human samples of stomach tumors, lung tumors, kidney tumors, non-Hodgkin-lymphoma, colon carcinoma, astrocytoma, glioblastoma and breast cancer <ref type="bibr" target="#b15">(12)</ref><ref type="bibr" target="#b17">(13)</ref><ref type="bibr" target="#b19">(14)</ref><ref type="bibr" target="#b21">(15)</ref><ref type="bibr" target="#b22">(16)</ref><ref type="bibr" target="#b24">(17)</ref><ref type="bibr" target="#b26">(18)</ref><ref type="bibr" target="#b28">(19)</ref><ref type="bibr" target="#b30">(20)</ref><ref type="bibr" target="#b31">(21)</ref>.</s><s>In particular, in breast cancer, high SPHK1 expression is associated with unfavorable prognosis <ref type="bibr" target="#b30">(20,</ref><ref type="bibr" target="#b31">21)</ref>.</s><s>Furthermore, in-vitro-SPHK1-overexpression leads to transformation of benign NIH3T3 fibroblasts into fibrosarcomas <ref type="bibr" target="#b50">(36)</ref>.</s><s>This phenomenon is reversible after competitive SPHK1 inhibition with N,N'-dimethyl-sphingosine <ref type="bibr" target="#b50">(36)</ref>.</s><s>Moreover, SPHK1 expression levels are positive correlated with chemotherapy resistance in prostatic tumor cells, pancreatic tumor cells and leukemia cells <ref type="bibr" target="#b38">(25)</ref><ref type="bibr" target="#b39">(26)</ref><ref type="bibr" target="#b41">(27)</ref><ref type="bibr" target="#b42">(28)</ref>.</s><s>Also, increased doxorubicin-induced apoptosis rates are demonstrated in breast cancer, gliobastoma and colon tumor SPHK2-siRNA-knockout-celllines <ref type="bibr" target="#b22">(16,</ref><ref type="bibr" target="#b51">37)</ref>.</s></p><p><s>Further experiments manipulating sphingolipid metabolism enzymes in chemotherapyresistance retinoblastoma cells are planned in order to better understand the significance of sphingosine-1-P function in retinoblastoma chemotherapy resistance and chemotherapy vulnerability in these cells.</s><s>Normalization was done using the expression of ß2-microglobulin as reference.</s></p><p><s>Expression levels are calculated from RT-qPCR ΔC T means as 2 (-ΔCT)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>7</head><label></label><figDesc><div><p><s>etoposide incubation for 24 hours (fig 2).</s><s>Glucosyl-ceramide, ceramide, sphingosine and sphingosin-1-P quantification WERI Rb1 and WERI EtoR were incubated with DMEM supplemented with 400 ng/ml etoposide or vehicle control for 24 hours.</s><s>Ceramides, sphingosine and S1P were extracted and quantified as recently described (31-33).</s><s>Briefly, lipid extraction of cells was performed using C17-sphingosine, C17-S1P and C17-ceramide as internal standards.</s><s>Sample analysis was carried out by rapid resolution LC-MS/MS using a QTOF 6530 mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in the positive ESI mode.</s><s>The precursor ions of sphingosine (m/z 300.289,)</s><s>C17sphingosine (m/z 286.274),</s><s>S1P (m/z 380.256),</s><s>C17-S1P (m/z 366.240),</s><s>C16-ceramide (m/z 520.508) and C17-ceramide (m/z 534.524) were cleaved into the fragment ions of m/z 282.280 for sphingosine, m/z 268.264 for C17-sphingosine, m/z 264.270, m/z 250.252 for S1P, m/z 264.270 for C17-S1P and m/z 264.270 for ceramides, respectively.</s><s>Quantitation was performed with Mass Hunter Software.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>patients experienced bilateral retinoblastoma and one patient only unilateral retinoblastoma.</s><s>None of the four patients have been diagnosed with metastasis or had risk factors for metastasis.</s><s>All data have been displayed in tab 1. Etoposide-induced upregulation of apoptotic sphingosine in WERI Rb1 and WERI EtoR WERI Rb1 vehicle control, WERI Rb1 400 ng/ml etoposide, WERI EtoR vehicle, and WERI EtoR 400 ng/ml etoposide were incubated with DMEM supplemented with etoposide or vehicle control and harvested after 24 hours.</s><s>Levels for apoptotic glucosylceramide, ceramide and sphingosine were evaluated by mass spectroscopy for all treatment groups.</s><s>Statistical significant upregulation of apoptotic sphingosine was seen after etoposide treatment in WERI Rb1 and WERI EtoR (p&lt;0.01,</s><s>fig 3 A, absolute values and SD values tab 3).</s><s>Slight downregulation of ceramide and glu-ceramide were seen after etoposide treatment in WERI Rb1 and WERI EtoR, but this was only statistical significant for ceramide in WERI Rb1 after etoposide treatment (p&lt;0.5;</s><s>fig 3 B and D, absolute values and SD values tab 3).</s><s>Etoposide-induced upregulation of survival favoring sphingosine-1-P only in etoposide resistant WERI EtoR WERI Rb1 vehicle control, WERI Rb1 400 ng/ml etoposide, WERI EtoR vehicle, and WERI EtoR 400 ng/ml etoposide were incubated with DMEM supplemented with etoposide or vehicle control for 24 hours and were harvested.</s><s>Levels for survival favoring sphingosine-1-P were evaluated by mass spectroscopy.</s><s>Statistical significant upregulation of sphingosine-1-P was seen after etoposide treatment in therapy resistant WERI EtoR, but not in therapy sensitive WERI Rb1 (p&lt;0.01,</s><s>fig 3 C, absolute values and SD values tab 3) Quantitative sphingolipid enzyme expression in human retinoblastoma samples and in WERI Rb1 and WERI EtoR mRNA expression of sphingolipid metabolism enzymes was measured by quantitative PCR in four human retinoblastoma samples and in WERI Rb1 and WERI EtoR.</s><s>Fig 4 displays the relative expression of sphingosine kinase 1 (SPHK1), sphingosine kinase 2 (SPHK2), sphingosphingosine-1-phosphate receptor 1 (S1P1), sphingosphingosine-1phosphat receptor 2 (S1P2), sphingosphingosine-1-phosphate receptor 3 (S1P3), sphingosphingosine-1-phosphate receptor 4 (S1P4), sphingosphingosine-1-phosphate receptor 5 (S1P5), sphingosphingosine-1-phosphate phosphatase 1 (SGPP1), sphingosphingosine-1-phosphate phosphatase 2 (SGPP2), ceramide synthase 1 (LASS1), ceramide synthase 2 (LASS2), ceramide synthase 3 (LASS3), ceramide synthase 4 (LASS4), ceramide synthase 5 (LASS5), ceramide synthase 6 (LASS6), acid ceramidase 1 (ASAH1), acid ceramidase 2 (ASAH2), alkaline ceramidase 1 (ACER1), alkaline ceramidase 2 (ACER2), alkaline ceramidase 3 (ACER3), ceramide kinase (CERK), ceramide kinase like (CERKL), sphingomyelin synthase 1 (SGMS1), sphingomyelin synthase 2 (SGMS2), acid sphingomyelinase 1 (SMPD1), neutral 12 sphingosphingomyelinase 2 (SMPD2), neutral sphingomyelinase 3 (SMPD3), neutral sphingomyelinase 4 (SMPD4), alkaline sphingomyelinase (ENPP7)).</s><s>No expression or almost no expression has been detected for ACER1, ASAH2, ENPP7, S1P1 S1P4 and S1P5 in retinoblastoma tissue, WERI Rb1 and WERI EtoR.</s><s>For ASAH1, CERK, LASS1, LASS2, LASS6, S1P3, SGPP1, SGPP2, SMPD2 and SPHK1 lowest expression was seen in retinoblastoma tissue and highest in WERI EtoR.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 1</head><label>1</label><figDesc><div><p><s>Fig 1 Schematic cascade of sphingolipid metabolism</s></p></div></figDesc><graphic coords="20,70.80,70.70,470.15,352.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 2</head><label>2</label><figDesc><div><p><s>Fig 2 DAPI/propidium iodide assays</s></p></div></figDesc><graphic coords="21,70.80,70.80,467.75,204.70" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 3</head><label>3</label><figDesc><div><p><s>Fig 3 Sphingolipid measurements</s></p></div></figDesc><graphic coords="22,70.80,98.30,465.00,327.80" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 4</head><label>4</label><figDesc><div><p><s>Fig. 4 Normalized gene expressions of proteins of the ceramide pathway in</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="24,70.80,70.70,437.90,663.70" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Clinical and histopathological features of the four patients with retinoblastoma</head><label></label><figDesc><div><p><s>. Statistical analysis was done by Anova with Tukeys post-test.</s><s>p values &lt; 0.05 are set as significant (*); p &lt; 0.01 as **, p &lt; 0.001 as ***.</s><s>Clinical and pathological TNM classification, age, histology, previous treatment, previous treatment, unilateral or bilateral cases, isolated or heritable, and risk factors for metastasis have been listed.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>pathological</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>clinical TNM</cell><cell>TNM</cell><cell></cell><cell></cell><cell></cell><cell>unilateral/</cell><cell>isolated/</cell><cell></cell></row><row><cell>patient</cell><cell>classification</cell><cell>classification</cell><cell>age</cell><cell>histology</cell><cell>previous treatment</cell><cell>bilateral</cell><cell>heritable</cell><cell>risk factors</cell></row><row><cell>1</cell><cell>ycTxNxMxRxLxVx</cell><cell>ypT1NxMXRxLxVx</cell><cell>2m</cell><cell>endophytic</cell><cell>non</cell><cell>bilateral</cell><cell>unknown</cell><cell>none</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>5 cycles</cell><cell></cell><cell></cell><cell></cell></row><row><cell>2</cell><cell>ycT1NxMxRxLxVx</cell><cell>ypT1NxMXRxLxVx</cell><cell>6y 6m</cell><cell>exophytic</cell><cell>chemotherapy</cell><cell>bilateral</cell><cell>isolated</cell><cell>none</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>7 cycles</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>chemotherapy</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>external beam</cell><cell></cell><cell></cell><cell></cell></row><row><cell>3</cell><cell>ycT1NxMxRxLxVx</cell><cell>ypT1NxMXRxLxVx</cell><cell>1y 8m</cell><cell>exophytic</cell><cell>radiotherapy</cell><cell>bilateral</cell><cell>unknown</cell><cell>none</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>external beam</cell><cell></cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>ycT2NxMxRxLxVx</cell><cell>ypT1NxMXRxLxVx</cell><cell>6y 5m</cell><cell>endophytic</cell><cell>radiotherapy</cell><cell>unknown</cell><cell>unknown</cell><cell>none</cell></row><row><cell cols="2">Tab. 1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acknowledgement: We thank C Gavranic, S Metzner, G Fels and N Gimbel for their technical support in these experiments.</s></p><p><s>Authors funding: This study was supported by Jackstädt-Stiftung S 134-10.063</s><s>(V Kakkassery) and Deutsche Forschungsgemeinschaft DFG KL988/4-4 (B Kleuser)</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Kingston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="576" to="583" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Update on retinoblastoma</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Abramson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Schefler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Retina</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="828" to="848" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bornfeld</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Current therapy aspects of intraocular tumors</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ophthalmologe</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="207" to="222" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Shields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Potter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Himelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Shields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Meadows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Maris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Chemoreduction in the initial management of intraocular retinoblastoma</title>
	</analytic>
	<monogr>
		<title level="j">Arch Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1330" to="1338" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Himelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Shields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Shields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Needle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Miller</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma</title>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12" to="17" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">External beam radiotherapy for retinoblastoma: II. Lens sparing technique</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Toma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hungerford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Plowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Kingston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Doughty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="112" to="117" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Whole-eye versus lens-sparing megavoltage therapy for retinoblastoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hungerford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Toma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Plowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Doughty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Kingston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Radiat Ther Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="81" to="87" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Intraarterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Abramson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Marr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Dunkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brodie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Zabor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Driscoll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="499" to="502" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Shields</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Manjandavida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pieretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Arepalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Caywood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ophthalmology</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1453" to="1460" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Munier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beck-Popovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Balmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Gaillard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bovey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Binaghi</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma</title>
	</analytic>
	<monogr>
		<title level="j">Retina</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="566" to="573" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Principles of bioactive lipid signalling: lessons from sphingolipids</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Hannun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Obeid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="139" to="150" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">X</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Q</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sphingosine kinase</title>
		<imprint>
			<biblScope unit="page">1</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">is associated with gastric cancer progression and poor survival of patients</title>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1393" to="1399" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Schrecengost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Eberly</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Discovery and evaluation of inhibitors of human sphingosine kinase</title>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="5962" to="5969" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Crellin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ogretmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Boylan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Harley</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue</title>
	</analytic>
	<monogr>
		<title level="j">J Histochem Cytochem</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1159" to="1166" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="6996" to="7003" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Van Brocklyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Pearl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kotur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Snyder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Prior</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines</title>
	</analytic>
	<monogr>
		<title level="j">Journal of neuropathology and experimental neurology</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="695" to="705" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Momoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Oo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Venkataraman</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation</title>
	</analytic>
	<monogr>
		<title level="j">Molecular and cellular biology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="7211" to="7223" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Kawamori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kaneshiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okumura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Maalouf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uflacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bielawski</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Role for sphingosine kinase 1 in colon carcinogenesis</title>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="405" to="414" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Bayerl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Bruggeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Conroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hengst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jimenez</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions</title>
	</analytic>
	<monogr>
		<title level="j">Leukemia &amp; lymphoma</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="948" to="954" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ruckhaberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Engels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gaetje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Von Minckwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schiffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Breast cancer research and treatment</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="41" to="52" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">Increased ceramide synthase 2 and 6</title>
		<author>
			<persName><forename type="first">R</forename><surname>Erez-Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pienik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Futerman</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochemical and biophysical research communications</title>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="219" to="223" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><surname>Grammatikos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Teichgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carpinteiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Trarbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hengge</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy</title>
		<author>
			<persName><surname>Ur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid Redox Signal</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1449" to="1456" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Paris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Miranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ehleiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haimovitz-Friedman</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy</title>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1109" to="1114" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lacour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hammann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grazide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lagadic-Gossmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Athias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sergent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3593" to="3598" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Akao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Banno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murate</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemical and biophysical research communications</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1284" to="1290" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Pchejetski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Golzio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bonhoure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Calvet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Doumerc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Garcia</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models</title>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="11667" to="11675" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug</title>
		<author>
			<persName><forename type="first">J</forename><surname>Guillermet-Guibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Davenne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pchejetski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Saint-Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Brizuela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guilbeau-Frugier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Molecular cancer therapeutics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="809" to="820" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Baran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Salas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Senkal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Gunduz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bielawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Obeid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="10922" to="10934" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines</title>
		<author>
			<persName><forename type="first">H</forename><surname>Stephan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Boeloeni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eggert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bornfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schueler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Invest Ophthalmol Vis Sci</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3158" to="3163" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Altered calcium regulation by thermosensitive transient receptor potential channels in etoposideresistant WERI-Rb1 retinoblastoma cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mergler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Skosyrski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garreis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pietrzak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kociok</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Eye Res</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="157" to="173" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa</title>
		<author>
			<persName><forename type="first">J</forename><surname>Steinmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO Mol Med</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Sphingosine 1-phosphate counteracts insulin signaling in pancreatic beta-cells via the sphingosine 1-phosphate receptor subtype 2</title>
		<author>
			<persName><forename type="first">L</forename><surname>Japtok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fayyaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kleuser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gulbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Palmada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reichel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bohmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Amato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="934" to="938" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Coulouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Zaretskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cutcutache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rozen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Madden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">134</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sobue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nemoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International journal of hematology</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="266" to="275" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">An oncogenic role of sphingosine kinase</title>
		<author>
			<persName><forename type="first">P</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gamble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Pitson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Moretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Wattenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current biology : CB</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="1527" to="1530" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Sankala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Hait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Paugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lepine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Elmore</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin</title>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="10466" to="10474" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
